RDNT EBITDA
$277.42MTTM · USD
Period ending:
RDNT FY EBITDAUSD
$292.79M-$44.15M
1995-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
RDNT ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 31 observations from Dec 31, 1995 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 253,949,000 | |
| 262,549,000 | |
| 292,786,000 | |
| 278,534,000 | |
| 278,370,000 | |
| 199,738,000 | |
| 225,162,000 | |
| 107,599,000 | |
| 119,809,000 | |
| 108,734,000 | |
| 116,940,000 | |
| 114,917,000 | |
| 104,331,000 | |
| 108,506,000 | |
| 105,902,000 | |
| 81,139,000 | |
| 85,375,000 | |
| 86,838,000 | |
| 67,524,000 | |
| 32,664,000 | |
| 30,936,000 | |
| 29,019,000 | |
| 29,300,000 | |
| 25,199,000 | |
| 28,649,000 | |
| 23,370,000 | |
| 9,900,000 | |
| -7,865,578 | |
| 1,777,060 | |
| 4,207,136 | |
| -44,153,957 |
Compare ebitda
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) ebitda
- Bridgebio Pharma Inc (BBIO) ebitda
- Brightspring Health Services Inc (BTSG) ebitda
- Madrigal Pharmaceuticals Inc (MDGL) ebitda
- Ensign Group Inc (ENSG) ebitda
- Glaukos Corp (GKOS) ebitda
- Vaxcyte Inc (PCVX) ebitda
- Krystal Biotech Inc (KRYS) ebitda
All RDNT financial metrics · RDNT stock overview · How to interpret financial metrics